Figure 2.
Boxplots, showing the differences of relative 3′-tRF-LeuAAG/TAG levels between multiple myeloma (MM) and smoldering MM (sMM) patients (A), and of relative i-tRF-GlyGCC levels between MM patients without and with osteolytic lesions (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.